Use of doxycycline for leptospirosis after high-risk exposure in São Paulo, Brazil.

Gonsalez, C R; Casseb, J; Monteiro, F G; Paula-Neto, J B; Fernandez, R B; Silva, M V; Camargo, E D; Mairinque, J M; Tavares, L C

Gonsalez, C R; Casseb, J; Monteiro, F G; Paula-Neto, J B; Fernandez, R B; Silva, M V; Camargo, E D; Mairinque, J M; Tavares, L C.

Rev Inst Med Trop Sao Paulo ; 40(1): 59-61, 1998.

Article in En | MEDLINE | ID: mdl-9713140

Subject(s)

Anti-Bacterial Agents/therapeutic use; Doxycycline/therapeutic use; Leptospirosis/prevention & control; Adolescent; Adult; Aged; Antibodies, Bacterial/blood; Brazil; Confidence Intervals; Double-Blind Method; Environmental Exposure; Female; Humans; Immunoglobulin M/blood; Leptospira/immunology; Leptospirosis/diagnosis; Leptospirosis/immunology; Male; Middle Aged; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Peloideterapia Main subject: Doxycycline / Leptospirosis / Anti-Bacterial Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Rev Inst Med Trop Sao Paulo Year: 1998 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links